Microbot Medical
MBOT
28 hedge funds and large institutions have $6.54M invested in Microbot Medical in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 6 closing their positions.
101% more capital invested
Capital invested by funds: $3.25M → $6.54M (+$3.29M)
2.05% less ownership
Funds ownership: 14.24% → 12.19% (-2.1%)
10% less funds holding
Funds holding: 31 → 28 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$349K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.35K |
| 3 |
KPW
Kore Private Wealth
New York
|
+$1.32K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$1.17K |
| 5 |
Bank of New York Mellon
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$74.9K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$43K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$29.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.8K |
| 5 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$11K |
MBOT Hedge Fund Activity: Q4 2019 in Review
28 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2019, worth a combined $6.54M — up 101% from $3.25M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MBOT and 3 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 5 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $349K. The largest seller was Renaissance Technologies, cutting an estimated $74.9K.
- 28 institutional investors held Microbot Medical (MBOT) as of Q4 2019, down from 31 in Q3 2019.
- Funds reported $6.54M of Microbot Medical stock for Q4 2019, up 101% quarter-over-quarter.
- 3 funds opened new Microbot Medical positions in Q4 2019 and 6 closed out, a net change of -3 holders.
- The largest Microbot Medical buyer in Q4 2019 was Virtu Financial, an estimated $349K added.
- The largest Microbot Medical seller in Q4 2019 was Renaissance Technologies, an estimated $74.9K sold.
Based on aggregated 13F filings for Q4 2019.